NEW Podcast #GLP-1s, Weight and #Exercise in #MS Impact on inflammation & neuroplasticity! Dr. Stuve @UTSWMedCenter & Trevor @MSGym1 bit.ly/4zNjTiT🍏apple.co/4iFQH7i @narologist @jsabatino37 @C_OrejaGuevara @anneke_vdw #NeuroTwitter Sponsor: @TGTherapeutics

Worried your MS therapy raises your cancer risk? The long-term data may surprise you. New #MSLivingWell episode🎧Drs. Esther Melamed & Melinda Magyari; Host @brainboyneuro1 bit.ly/3TdjnKM 🍏apple.co/46HoeXF @MStranslate @MustStopMS @themsguide @MarkWebb_

Worried your MS therapy raises your cancer risk? The long-term data may surprise you. New #MSLivingWell episode🎧Drs. Esther Melamed & Melinda Magyari; Host @brainboyneuro1 bit.ly/3TdjnKM 🍏apple.co/46HoeXF @Brandon_Beaber @MSViewsandNews Sponsor: @TGTherapeutics

Can targeted exercise rewire the brain to improve function in #MS? Trevor Wicken @TheMSGym1 shares strategies on New MS Living Podcast. bit.ly/4zNjTiT🍏apple.co/4iFQH7i @MustStopMS @eurims @DrJNicholas @MarkWebb_

Could #GLP1 meds like Ozempic/Mounjaro do more for people with #MS than weight loss? Reduce inflammation, neuroprotection & myelin repair? New Podcast🎧 Guest: Dr. Stuve @UTSWMedCenter bit.ly/4zNjTiT🍏apple.co/4iFQH7i @Brandon_Beaber @MSViewsandNews @MStranslate

👏Phase 3 REMODEL #remibrutinib relapsing #MS: Superior⬇️ annualized relapse rate (ARR) & inflammatory brain lesions vs. teriflunomide. Positive trend in 3-month confirmed disability progression. Favorable safety profile with no liver safety signal. #BTKi bit.ly/4h6Douv

#CAREGIVING for someone with #MS? 🎧 Listen in to this new episode on MS Living Well podcast with @KennethPakenham, Dan Shaul & @brainboyneuro1 bit.ly/4pBqrg2 🍏apple.co/4fNsRoc @KlausSchmierer @C_OrejaGuevara @anneke_vdw @bart_professor Sponsor: @TGTherapeutics

👫Caring for someone with MS? 🎧Tune into new Caregiving episode on MS Living Well podcast with @KennethPakenham & Dan Shaul. Host: @brainboyneuro1 bit.ly/4pBqrg2 🍏apple.co/4fNsRoc @Brandon_Beaber @MustStopMS @MSViewsandNews @DanJenDig @MarkWebb_ @MStranslate

Working with #MS? 💼 From accommodations to long-term disability, understand your options! @brainboyneuro1 guests: #employment expert Dr. Rumrill & #disability attorney Jamie Hall. bit.ly/3Qyknb3🍏apple.co/3STA9hg #NeuroTwitter Sponsor: @TGTherapeutics @DrJim4MS

Worried about how #MS might affect your job? New MS Living Well podcast with #employment expert Dr. Phillip Rumrill & #disability attorney Jamie Hall. 🎧bit.ly/3Qyknb3🍏apple.co/3STA9hg @DanJenDig @MarkWebb_ @Brandon_Beaber @MustStopMS @DocforMS @MSViewsandNews

New MRI techniques are uncovering hidden inflammation ongoing even when someone feels their MS is stable. New MS Living Well podcast 🎧 bit.ly/4dK0Ay8🍏apple.co/4vmB1sG @brandon_beaber @MSViewsandNews @themsguide @MustStopMS @DocforMS @DrJim4MS @narologist

Beyond White Spots: Rethinking MRI in MS New MS Living Well podcast 🎧 Profs. Barkhof & Traboulsee bit.ly/4dK0Ay8🍏apple.co/4vmB1sG @KlausSchmierer @C_OrejaGuevara @anneke_vdw @MSCanOfficial @MStranslate #neurotwitter Sponsor: @TGTherapeutics

Why can’t I find the right word? In MS, it’s often not memory loss—it’s difficulty accessing info. New MS Living Well pod episode: Word-finding & memory strategies 🎧 bit.ly/4d6Js5e🍏bit.ly/4d6Js5e @TrippingOnAir @MarkWebb_ @DamianWashington @RachelHorne19

New MS Living Well podcast 🎧🗣️🧠 Handling MS: Word-Finding and Memory Strategies with @jfsumowski & Dr. Barrera bit.ly/4d6Js5e🍏bit.ly/4d6Js5e Sponsor: @TGTherapeutics @TheMSGuide @MSViewsandNews @SKriegerMD

You’re not losing your words—you’re having trouble accessing them. We dive into working memory & word-finding in MS—and what actually helps. New MS Living Well podcast 🎧 bit.ly/4d6Js5e🍏bit.ly/4d6Js5e @C_OrejaGuevara @KlausSchmierer @MStranslate @MustStopMS

Phase 3 PERSEUS trial results in primary progressive multiple sclerosis #PPMS patients. No significant benefit of #tolebrutinib vs. placebo on primary endpoint of time to 6-month cCDP (disability measure). However, positive impact of brain volume. @ACTRIMS #ACTRIMSForum

Phase 2 Relapsing #MS MoonStone 12-week results: 95% reduction in contrast-enhancing lesions compared to placebo. #Obexelimab is a humanized monoclonal antibody that inhibits CD19 and FcyRllb without inducing cytotoxicity. @ACTRIMS #ACTRIMSForum

Phase III FENtrepid Study: #Fenebritninb achieved noninferiority to ocrelizumab in reducing disability progression (cCDP12) in primary progressive multiple sclerosis #PPMS patients; actually 12% better. @ACTRIMS #ACTRIMSForum

Could an ingredient in walnuts help #MS? Dr. Jamie Holloman @brainboyneuro1 chats with Dr. Marianna Cortese and Dr. Eric Thouvenot. The Science of Supplements; a new MS Living Well podcast. bit.ly/3X4Y4t5 🍏apple.co/4844DRE @MSViewsandNews @lkay54 @DanJenDig

Curious about vitamins, nutrition & supplements for MS? New #MSLivingWell episode with Dr. Marianna Cortese & Dr. Eric Thouvenot, hosted by Dr. Jamie Holloman. bit.ly/3X4Y4t5 🍏apple.co/4844DRE @KlausSchmierer @C_OrejaGuevara @ConorKerley Sponsor @TGTherapeutics